Necrotizing fasciitis: a complication of percutaneous coronary revascularization. | Canada Hyperbarics Skip to main content
Clinical Study Angiology 2007

Necrotizing fasciitis: a complication of percutaneous coronary revascularization.

Calderon E, Carter E, Ramsey KM, Vande Waa JA, Green WK, Alpert MA — Angiology, 2007

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reported two cases of necrotizing fasciitis (NF) in patients who underwent percutaneous coronary revascularization for acute coronary syndrome.

What They Found

They found two patients developed necrotizing fasciitis (NF) after undergoing percutaneous transluminal coronary revascularization for acute coronary syndrome. These two cases represent the first reported instances of NF as a complication of this procedure.

What This Means for Canadian Patients

Canadian patients undergoing percutaneous coronary revascularization should be aware that, while rare, severe infections like necrotizing fasciitis can be a complication. Prompt recognition of unusual pain, swelling, or redness at the procedure site is crucial for early diagnosis and treatment.

Canadian Relevance

This study has no direct Canadian connection as it reports on cases from outside Canada.

Study Limitations

A significant limitation of this study is its reliance on only two case reports, which limits the generalizability of the findings to a broader patient population.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Infection
Source Pubmed
PubMed ID 17626992
Year Published 2007
Journal Angiology
MeSH Terms Angioplasty, Balloon, Coronary; Anti-Bacterial Agents; Debridement; Fasciitis, Necrotizing; Humans; Hyperbaric Oxygenation; Male; Middle Aged; Peptostreptococcus; Propionibacterium; Skin Transplantation; Stents; Treatment Outcome

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.